Dr. Jonathan Trent on FDA Approval of Trabectedin for Soft Tissue Sarcomas
14 بازدیدها
• 07/18/23
0
0
جاسازی کنید
administrator
مشترکین
Jonathan C. Trent, MD, professor of Medicine, co-director, Musculoskeletal Center, Sarcoma Medical Research Program, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, discusses the FDA approval of trabectedin for patients with soft tissue sarcomas.
بیشتر نشان بده، اطلاعات بیشتر
نظرات فیس بوک
SORT BY-
نظرات برتر
-
آخرین نظرات